Colinz Laboratories Limited Stock

Equities

COLINZ6

INE923C01011

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:54 2024-04-29 EDT 5-day change 1st Jan Change
39.43 INR -4.30% Intraday chart for Colinz Laboratories Limited -6.81% -1.42%

Financials

Sales 2022 69.74M 836K 1.14M Sales 2023 71.55M 858K 1.17M Capitalization 160M 1.92M 2.62M
Net income 2022 3M 35.96K 49.11K Net income 2023 4M 47.95K 65.48K EV / Sales 2022 0.87 x
Net cash position 2022 47.22M 566K 773K Net cash position 2023 54.55M 654K 893K EV / Sales 2023 1.47 x
P/E ratio 2022
31.8 x
P/E ratio 2023
19.2 x
Employees 67
Yield 2022 *
-
Yield 2023
-
Free-Float 31.46%
More Fundamentals * Assessed data
Dynamic Chart
Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Colinz Laboratories Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Colinz Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Colinz Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Colinz Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Colinz Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Colinz Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Colinz Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Colinz Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
More news
1 day-4.30%
1 week-6.81%
Current month+5.01%
1 month+1.36%
3 months+3.36%
6 months+1.44%
Current year-1.42%
More quotes
1 week
39.00
Extreme 39
46.54
1 month
37.55
Extreme 37.55
46.90
Current year
37.00
Extreme 37
46.90
1 year
33.35
Extreme 33.35
46.90
3 years
12.35
Extreme 12.35
61.15
5 years
4.80
Extreme 4.8
61.15
10 years
3.56
Extreme 3.56
61.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 71 90-11-25
Director of Finance/CFO - 19-05-19
Compliance Officer 73 94-09-30
Members of the board TitleAgeSince
Compliance Officer 73 94-09-30
Chief Executive Officer 71 90-11-25
Director/Board Member 52 03-03-18
More insiders
Date Price Change Volume
24-04-29 39.43 -4.30% 1 685
24-04-26 41.2 +0.07% 1,086
24-04-25 41.17 -4.26% 3,310
24-04-24 43 +6.81% 1,577
24-04-23 40.26 -4.85% 2,703

Delayed Quote Bombay S.E., April 29, 2024 at 06:00 am

More quotes
Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company is engaged in the manufacturing and marketing various allopathic and ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. It provides physicians with products in the treatment of hypertension, cholesterol, diabetes, piles, pyrexia and malaria. It provides gynecologists with specialized products in the treatments of morning sickness, infertility, intrauterine growth restriction (IUGR) and maintenance of pregnancy. It also offers other products, such as hematinic, antispasmodics, anti-inflammatory/anti-allergic tablets, capsules gel and medicated shampoo. The Company markets its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh and West Bengal through its own marketing staff.
More about the company
  1. Stock Market
  2. Equities
  3. COLINZ6 Stock